AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2022

Mar 16, 2022

34999_dirs_2022-03-16_e09fd093-17bd-4cbb-b75f-ca9c6accd68f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2022-03-10

Reporting Person: Barr Jason Michael (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-10	Common Stock, par value $0.0005	P	750	$6.48	Acquired	30991	Direct

Footnotes

F1: The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program.